Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
This report indicates that babesiosis, a tickborne disease caused by Babesia parasites, has significantly increased in northeastern states in the last decade.
A resurgence of invasive group A Streptococcus infection in children and adolescents was observed in two of CDC's Emerging Infections Program surveillance sites during fall 2022.
This study assessed racial, ethnic, demographic, and geographical differences in prevalence of subjective cognitive decline, and prevalence of health care conversations among those reporting SCD.
The findings in this report suggest that undetected mpox infections might have occurred among a small percentage of persons experiencing homelessness in a large metropolitan area.
These cases illustrate the ubiquity of Cronobacter sakazakii in the environment and the importance of hygiene in preventing potentially devastating C. sakazakii infections.
A better understanding of the factors that may impact the likelihood of receiving a COVID-19 vaccine booster dose could help improve vaccination coverage.
This analysis confirms that receipt of the bivalent booster added significant protection against infection and death for circulating Omicron BA.4/BA.5 sublineages.
Review vaccine-specific changes in the 2023 immunization schedule for adults aged 19 years and older, including updates to influenza, hepatitis B, and pneumococcal vaccination.
Review the new or updated ACIP recommendations in the 2023 Child and Adolescent Immunization Schedule including for influenza, MMR, COVID-19, and more.
With the FDA withdrawal of Evusheld as preexposure prophylaxis against SARS-CoV-2 infection, the CDC recommends all immunocompromised persons create an action plan against COVID-19.
This study confirms that a bivalent mRNA booster dose provides additional protection against symptomatic XBB/XBB.1.5 infection for at least 3 months after vaccination.
This report reveals that complete COVID-19 vaccination coverage among older adults in 2022 was substantially below the WHO goal, especially in middle- and low-income countries.
Nursing home residents had substantial antibody response after receiving the bivalent COVID-19 booster, irrespective of previous infection or receipt of monovalent boosters, according to this report.
This study found that incidence rates of COVID-19 among nursing home residents who weren't up to date with COVID-19 vaccines were 30%-50% higher than among those up to date with bivalent boosters.
